News

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
Merck KGaA Lowers Outlook on Tariff Risks, Currency Headwinds
Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...
One estimate of the profit hit from Trump's executive order on drug pricing
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
pharmaphorum6d
Merck sues US govt over Inflation Reduction Act
Merck & Co has filed a lawsuit against ... and Human Services will be able to negotiate the prices of selected drugs with a “high budget impact” provided via Medicare Parts B and D, starting ...
Merck’s New Keytruda Shot Is a Rare Real-Time ‘Product Hop’ (1)
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Trump's plans to assess tariffs on imported drugs could raise prices, cause drug shortages
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...
Reuters7d
Merck & Co Inc
US court shuts down AstraZeneca's challenge to Medicare drug price ... on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. manufacturing. Merck to invest ...